triptans

DRUG4 trials

Sponsors

European Institute for Evidence Based Osteopathic Medicine, Guangdong Provincial People's Hospital, Pfizer, Ain Shams University

Conditions

MigraineMigraine DiseaseMigraine HeadacheMigraine Headache, With or Without AuraMigraine, AcutePFO - Patent Foramen Ovale

Phase 3

Effectivity and Safety of PFO Closure vs Medicine in Alleviating Migraine

Active, not recruitingNCT04946734

Guangdong Provincial People's HospitalMigraine, PFO - Patent Foramen Ovale

Start: 2021-08-12End: 2025-09-06Target: 440Updated: 2025-03-12

Phase 4

Assessment of Oral Caffeine Intake in Changing the Severity of Acute Migraine Attack Using VAS Score Among Patients Attending Headache and Neurology Outpatients Clinic of Ainshams University Hospitals

RecruitingNCT07022496

Ain Shams UniversityMigraine, Migraine, Acute, Migraine Disease +2

Start: 2023-04-26End: 2025-08-31Target: 120Updated: 2025-06-15

Unknown Phase

Clinical Effectiveness of Osteopathic Manipulative Treatment in Chronic Migraine

CompletedNCT01851148

European Institute for Evidence Based Osteopathic MedicineMigraine

Start: 2010-03-31End: 2012-03-31Updated: 2013-09-04

Comparison of Patient-reported Outcomes for Rimegepant and Triptans in the 2023 US National Health and Wellness Survey

CompletedNCT06680206

Start: 2024-10-10End: 2024-11-20Updated: 2026-01-22

Related Papers

Rationale and design of the SPRING trail: effectivity and safety of Pfo closuRe vs medIcine in alleviatiNg migraine, a multicenter, randomized and open-label trail

BMC Cardiovascular Disorders2024-04-05

Clinical effectiveness of osteopathic treatment in chronic migraine: 3-Armed randomized controlled trial.

2015-01-2161 citations